JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
Update: 2012-09-21
Description
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
- In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
- CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
- In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should be used in routine clinical practice, however, is still a matter of personal opinion or further research.
Comments
In Channel